Greg Abel Running Berkshire: Early Moves Define Era
Greg Abel is redefining Berkshire Hathaway’s course with three bold moves: pruning a laggard investment, expanding ho...
This walkthrough guides you through stock index calculation with a concrete example, detailing data inputs, weighting decisions, and the final result.
17,212 articlesGreg Abel is redefining Berkshire Hathaway’s course with three bold moves: pruning a laggard investment, expanding ho...
Recalls are part of the auto business, but the year, same ford problem: can still test investors. This article breaks...
Goldman Sachs and JPMorgan cut targets on Kohl’s as consumer demand cools, signaling a tougher 2026. The moves come a...
Hims & Hers Health shifts to selling branded Wegovy and Ozempic after a settlement with Novo Nordisk, reversing regul...
Oil prices retreat, lifting major indexes as traders react to easing energy costs and a cautious economic backdrop. T...
A week of trouble tested Amazon's operations and investor nerves. This article breaks down two essential takeaways an...
When markets wobble, income-focused investors flock to high-yield ETFs. This piece dives into why the JPMorgan Equity...
GLAD faces a delicate turning point as the Fed freezes rates, pressuring yields on its floating-rate loans while port...
GameStop delivers a strong Q4 with a record cash balance and earnings beat, but the CEO’s silence on any megadeal kee...
Investors are weighing the beads-and-blood-screening company Cytosorbents as it reports 2025 earnings. This guide bre...
Palantir surged into focus after blowout Q1 results and a fresh Buy rating from Argus with a $190 target, raising que...
Biote's Q1 2026 earnings call reveals critical insights into revenue growth, margins, and a promising pipeline. This ...